Patients Informed to Exchange Emerade 500 Micrograms Adrenaline Pens for a Different Brand Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand. Published 18 May 2020 From: Medicines and Healthcare products Regulatory Agency Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand. Healthcare professionals are being asked to contact patients who use Emerade 500 microgram pens following notification by the Medicines and Healthcare products Regulatory Agency (MHRA). Patients and/or carers should return all Emerade
The post Patients Informed to Exchange Emerade 500 Micrograms Adrenaline Pens for a Different Brand appeared first on Government Online.